Skip to main content
logo
DAE HWA Pharmaceutical Co., Ltd. (KOSDAQ:067080)
South Korea flag South Korea · Delayed Price · Currency is KRW
11,010
+10 (0.09%)
At close: Aug 12, 2026

DAE HWA Pharmaceutical Financials Overview

Millions KRW. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
143,424143,060149,409141,359131,912117,159
Revenue Growth
-5.26%-4.25%5.70%7.16%12.59%7.14%
Gross Profit
47,60346,93952,21244,66145,61443,252
Operating Income
2,4873,1626,7121,9625,8473,284
Net Income
1,8221,654531.42-1,1471,1162,217
Earnings Per Share
102.8794.3330.00-65.4763.69127.00
EPS Growth
3.96%214.43%---49.85%-

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
10,5256,1027,86313,4587,96218,422
Total Debt
101,28196,77699,274110,52590,06670,150
Net Cash (Debt)
-90,755-90,674-91,411-97,067-82,104-51,728
Net Cash Growth
------
Net Cash Per Share
-5125.09-5172.72-5160.42-5541.39-4687.19-2962.69

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
1,2595,4285,250-214.418,19310,386
Capital Expenditures
-2,513-2,836-4,374-8,907-27,690-9,684
Free Cash Flow
-1,2552,591875.3-9,122-19,497701.81
Free Cash Flow Growth
-196.06%----

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
33.19%32.81%34.95%31.59%34.58%36.92%
Operating Margin
1.73%2.21%4.49%1.39%4.43%2.80%
Pretax Margin
3.26%3.34%1.01%-0.32%1.84%3.86%
Profit Margin
1.27%1.16%0.36%-0.81%0.85%1.89%
FCF Margin
-0.88%1.81%0.59%-6.45%-14.78%0.60%

Dividends
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22
Dividend Per Share
150.000--150.000150.000
Dividend Per Share Growth
0%--0%-
Dividend Yield
1.36%--1.65%1.67%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
44.36184.65360.61-147.5973.63
P/FCF Ratio
-117.82218.93--232.62
PS Ratio
1.302.131.281.161.251.39